- Company Overview for NEURAXPHARM UK LIMITED (10918621)
- Filing history for NEURAXPHARM UK LIMITED (10918621)
- People for NEURAXPHARM UK LIMITED (10918621)
- More for NEURAXPHARM UK LIMITED (10918621)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
05 Jun 2018 | AD01 | Registered office address changed from C/O Hackwood Secretaries Limited One Silk Street London EC2Y 8HQ United Kingdom to Unit 12 Farnborough Business Centre Eelmoor Farnborough Hampshire GU14 7XA on 5 June 2018 | |
25 Apr 2018 | TM01 | Termination of appointment of Daniel Wiest as a director on 6 April 2018 | |
25 Apr 2018 | AP01 | Appointment of Jan Christoph Koch as a director on 6 April 2018 | |
14 Nov 2017 | CERTNM |
Company name changed nupharm uk holding LIMITED\certificate issued on 14/11/17
|
|
17 Aug 2017 | AA01 | Current accounting period shortened from 31 August 2018 to 31 December 2017 | |
16 Aug 2017 | NEWINC |
Incorporation
Statement of capital on 2017-08-16
|